Group items tagged

Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world. Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning. The increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600 new cases of stomach cancer are expected to be diagnosed in the U.S. According to the World Cancer Research Fund, in 2018, over 1 million new cases of cancer were diagnosed across the globe. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/stomach-cancer-drugs-market-continues.html

Cancer is a disease caused when cells divide abnormally and uncontrollably and spread into surrounding tissues, which results in formation of a mass called tumor. Head and neck cancer refers to various malignant tumors that develop in or around the mouth, sinuses, nose, larynx, and throat. Moreover, head and neck cancer begin in squamous cells that line moist surfaces such as those inside the throat, nose, and mouth. Infection with human papillomavirus (HPV), excessive alcohol consumption, and chewing tobacco increases the risk of head and neck cancer. Other factors such as hereditary causes, Epstein barr virus infection, radiation exposure, occupational exposure, oral health, salted or preserved foods, excessive consumption of paan also increases the risk of head and neck cancer. Factors such as rise in government initiatives, surge in research and development activities, rise in health care infrastructure, and increase in the patient population are expected to propel the head and neck cancer market. Worldwide, head and neck cancer is the sixth-most common cancer, with around 630,000 people diagnosed every year, resulting in more than 350,000 deaths, according to the National Center for Biotechnology Information. Moreover, tens of millions of individuals are diagnosed with cancer each year and more than half of the patients eventually die from it. Moreover, cancer ranks the second most common cause of death in many countries, following cardiovascular diseases. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/head-and-neck-cancer-is-sixth-most.html

Bone cancer treatments are used all over the world, especially in regions such as the US, UK, and Italy. The standard bone cancer treatment of all types and stages of bone cancer consists of surgery. Surgeons will surgically remove the entire cancerous growth from the bone and surrounding healthy tissue, including lymph nodes. Sometimes, surgeons will only target the lymph nodes. In the bone, surgeons employ limb-sparing methods when possible. Radiation therapy as bone cancer treatment is often used for bone cancer treatment. This kind of treatment is very successful at removing all cancerous cells from the affected area. It uses high-energy radiation beams that are targeted at cancerous growth. Although radiation bone cancer treatment can remove some of the symptoms, it is not a guarantee of complete removal of the disease. This method may give an early diagnosis, but it does not guarantee a successful treatment. However, if this bone cancer treatment is conducted early enough, it will help to slow the spread of the disease. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/08/bone-cancer-treatments-are-administered.html

High prevalence of gastric cancer is expected to propel growth of the gastric cancer therapeutics market. For instance, according to The American Cancer Society, the U.S. is estimated to record about 26,560 cases of stomach cancer and about 11,180 people will die from this type of cancer in 2021. Moreover, R&D in oral chemotherapy for the treatment of gastric cancer is also expected to aid in growth of the market. For instance, in January 2021, Ascelia Pharma AB announced the clinical development plan for Oncoral, with which the company has the opportunity to develop a novel oral chemotherapy for the treatment of gastric cancer. Risk factors for gastric cancer may include smoking and a diet of highly processed or salty foods. Thus, high number of smokers is expected to offer lucrative growth opportunities for players in the gastric cancer therapeutics market. For instance, according to the World Health Organization's, May 2020 Update, tobacco leads to over 8 million deaths each year worldwide and over 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-gastric-cancer-and.html

Cancer is a disease caused when cells divide abnormally and uncontrollably and spread into surrounding tissues, which results in formation of a mass called tumor. Head and neck cancer refers to various malignant tumors that develop in or around the mouth, sinuses, nose, larynx, and throat. Moreover, head and neck cancer begin in squamous cells that line moist surfaces such as those inside the throat, nose, and mouth. Infection with human papillomavirus (HPV), excessive alcohol consumption, and chewing tobacco increases the risk of head and neck cancer. Other factors such as hereditary causes, Epstein barr virus infection, radiation exposure, occupational exposure, oral health, salted or preserved foods, excessive consumption of paan also increases the risk of head and neck cancer. Factors such as rise in government initiatives, surge in research and development activities, rise in health care infrastructure, and increase in the patient population are expected to propel the head and neck cancer market. Worldwide, head and neck cancer is the sixth-most common cancer, with around 630,000 people diagnosed every year, resulting in more than 350,000 deaths, according to the National Center for Biotechnology Information. Moreover, tens of millions of individuals are diagnosed with cancer each year and more than half of the patients eventually die from it. Moreover, cancer ranks the second most common cause of death in many countries, following cardiovascular diseases. Read more @ https://sachinbhombe.blogspot.com/2021/03/insights-on-salicylic-head-and-neck.html

Natural Killer cells are described as high, globular lymphocytes that are able to generate natural cytotoxic antibodies against cancer cells in a human body. These cells have the ability to kill even the living cells in a human body and apparently, the natural killer cells can also destroy cancer cells in a patient's body. Natural killer cells can also destroy leukemia, cancer, and lymphomas in humans. And since then, this technology has been improved to more precise results and can be applied in various experimental treatments. Increasing demand for natural killer cells for the treatment of cancer is a key factor driving the growth of the Natural Killer Cells market. According to the World Health Organization, Cancer is among the leading causes of death worldwide. In 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide. By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Moreover, it is also used in the treatment of other infections and liver diseases are again anticipated to augment the growth of the Natural Killer Cells market. The rise in the R&D for the development of specific antibodies for improving the activity of NK cells is further projected to accelerate the growth of the market over the forecast timeframe. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-cancer-around-globe.html

Radiofrequency ablation is a relatively new method of reducing pain associated with back pain. In a recent review published by an organization that studies medical innovations, the Global Commission on Systemic Palliative Care (GCSPC) stated that the most common application for radiofrequency ablation is the treatment of pain in the spine, which has been used since the 1970s. There are many other applications, although these are two examples of the typical type of pain that this device is used to relieve. Rising prevalence of cancer is expected to drive growth of the global radiofrequency ablation device market during the forecast period. The number of cancer cases has increased over the years globally. According to the World Health Organization (WHO), in 2018, around 18.1 million new cases of cancer and 9.6 million deaths due to cancer were reported globally. According to the same source, around 70% of deaths from cancer occur in emerging economies with lung cancer accounting for the majority of deaths followed by breast cancer. Furthermore, according to the National Cancer Institute, in 2020, around 1,806,590 new cases of cancer are expected to be diagnosed in the U.S. with over 600,000 people dying from this disease. Such high incidence of cancer has led to increased demand for radiofrequency ablation devices. Hence, these factors are expected to drive growth global radiofrequency ablation device market during the forecast period. Furthermore, rising prevalence of cardiovascular disease combined with increasing number of ablation procedures is expected to boost the global radiofrequency ablation device market growth over the forecast period. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/radiofrequency-ablation-device-market.html

Many people who have cancer are rather interested in trying anything that can cure them out of this in one piece including complementary and alternative cancer therapies. Alternative cancer treatments can offer some feeling of control over cancer but many alternative cancer treatments are unproven and can be even dangerous. Alternative treatments may not play a direct role in curing cancer but they can help the patients cope up with signs and symptoms such as anxiety, fatigue, nausea, and vomiting and pain difficulty in sleeping and stress may be lessened by alternative cancer treatments.

A cancer registry is the cancer cases which are registered in a population or specific country. In whole world mortality rate due to cancer is 20%. In USA cancer is the second largest disease of causing death after heart disease. Recently in 2016 estimated that 595,690 people die from this disease according to cancer statistics of National Cancer Institute USA.

Chronic lymphocytic leukemia is a cancerous disease in which cancer cells begin to multiply in the lymph cells. CLL is aggressive cancer that invades the lymphatic system and attacks healthy cells of the immune system. It typically affects the lymph nodes and T cells, although it can also affect any other cells in the human body. The combination of chemotherapy is aimed at destroying cancer cells while at the same time allowing the body's immune system to restore the damaged cells. This allows for a more rapid response to the infection and better overall outcomes. As a result of this combination, chemotherapy is often used to treat several types of cancer at one time. It has been very successful in achieving results against most types of cancer. The targeted drugs are given to make the cancer cells unable to multiply and thus stop their growth. Increasing prevalence of leukemia is expected to drive growth of the global chronic lymphocytic leukemia therapeutics market during the forecast period. According to the American Society of Clinical Oncology (ASCO), chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults aged 19 years and above with 37% of cases. According to the same source, around 21,040 new cases and 4,060 deaths are expected to occur in 2020 due to CLL in the U.S. Furthermore, according to the Leukemia & Lymphoma Society (LLC), in 2020, around 60,530 people are expected to be diagnosed with leukemia in the U.S. Such a high prevalence of CLL and leukemia has increased the demand for necessary therapeutics such as chemotherapy. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/chronic-lymphocytic-leukemia.html

Activating the immune system for therapeutic benefit in cancer has emerged as one of the most promising developments in immunology and oncology. In the past few decades, scientists have been trying to manipulate the human immune system to attack cancer cells. It's called immune therapy (or immunotherapy) and it works by harnessing the body's own natural killing cells to kill tumours. Cancer Immunotherapy has become a key part of treatment for many different types of the cancer.

A duodenoscope is a hollow, flexible, lighted tube that allows doctors to see the top of a patient's small intestine, or duodenum. It is used in diagnosis and treatment of severe, often life-threatening, diseases such as cancer or gallstones in the pancreas and bile ducts. The adoption of duodenoscopes is expected to increase significantly, owing to high prevalence of cancer and other chronic diseases. For instance, Japan recorded an age-standardized rate of 248 per 100,000 for cancer, as per Global Cancer Statistics 2018: GLOBOCAN. There are various different ways in which duodenoscopes can be used to help doctors see beyond the visible nose and throat area when performing a medical procedure. Nasal intraction with a duodenoscope is easiest performed with the device held horizontal and directly above the patient's nose and throat with the patient's chin slightly raised. When this procedure is performed correctly, there should be no visible scar from the edge of the windpipe to the base of the nose. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/high-prevalence-of-cancer-and-other.html

Breast cancer is the type of cancer that has a valid preventive strategy if we're talking about active prevention. There are about 1.38 million new cases and 458 000 deaths from breast cancer each year. Early diagnosis is a cornerstone for breast cancer care.

According to the World Health Organization, Breast Cancer is the most common form of cancer diagnosed in women and has become the leading cause of mortality amongst women globally. The incidence of breast cancer is rising sharply in developing countries due to changes in reproductive factors, increasing urbanization, adoption of western lifestyles, and increased life expectancy. Thirty percent of the breast cancers in India are in the second or third decade of life and they are resistant to the conventional mode of therapies.

The best hospitals for Prostate Cancer Treatment in India can go to any extent to treat a cancer patient, even if it makes them import a new technology from abroad

Enteral feeding devices technological advanced medical device used to deliver nutrition food directly to the stomach to the bedridden patient suffering from chronic diseases such as cancer and neurological disorder. The increase in the cases of malnutrition and premature birth cases around the globe is a prime factor driving growth of the enteral feeding devices market. Moreover, the growing prevalence of chronic diseases such as cancer and cardiovascular disease is another key factor fostering the market growth of the enteral feeding devices. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths occur due to cancer. Around 70% of deaths from cancer occur in low- and middle-income countries. Furthermore, increasing global expenditure on the healthcare sector for improving the patient care is further projected to augment the growth of the enteral feeding devices market. From the geographical perspective, North America is projected to gain significant growth over the forecast period and this is attributed to the high presence of the geriatric population prone to chronic disease that leads to digestive ailments. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/enteral-feeding-devices-to-gain.html

Early and correct detection of cancer is the most essential step in most cancer treatments, which could be financially very straining, whereas the identical is offered at affordable price by low cost radiologist in Mumbai